Novametrix pulse oximeter cleared by FDA:
This article was originally published in Clinica
Executive Summary
Novametrix Medical Systems has received US FDA clearance for its MARSpo2 Tech pulse oximeter. The device provides accurate oxygen and pulse rate information as well as enhancing pulse oximetry performance on patients who experience significant motion or who endure poor blood flow. The pulse oximeter alleviates problems associated with more traditional oximeters, including high operating costs and poor performance, the Wallingford, Connecticut-based company said.